![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi5sQ3NxQrsrun2Xit3jeRiE4KZGDNtkqyVxSwlCREG0KcRf6e8DA44UPVW3oLFXfyXY5_1c1E62xTOkdlm5Z4mV_JFm8FSgj1Juco_yCOuAJpQptHbIH6pOzuCmyTvl4SwcLDCIxvJl5mB/s200/imatinib.jpg) |
Image: www.genericmds.com |
Imatinib is generally well tolerated, but gastric antral vascular ectasia (GAVE) remains a rare but significant complication of imatinib therapy. Whilst this complication has been described in other disease settings, only one other case of GAVE has been reported in a chronic myeloid leukaemia (CML) patient receiving imatinib. Herein, we present three CML patients with GAVE complicating imatinib therapy. In all cases, GAVE resolved only with cessation of imatinib. This confirms a causal relationship between GAVE and imatinib. GAVE should be considered as a possible cause of anaemia and upper gastrointestinal bleeding in patients receiving imatinib therapy.
Reference: Ong, J., Yeung, D., Filshie, R., Hughes, T.P., Nandurkar, H. Imatinib-induced gastric antral vascular ectasia in three patients with chronic myeloid leukaemia. Int J Hematol. 2015 Jul 2. [Epub ahead of print]
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.